Literature DB >> 27923450

Strategies to use microRNAs as therapeutic targets.

Jan Krützfeldt1.   

Abstract

MicroRNAs (miRNAs) provide a unique mechanism of gene regulation and play a key role in different pathologies ranging from metabolic diseases to cancer. miRNAs can impact biological function as either suppressors of gene expression when their expression levels are enhanced in a disease state or they can cause upregulation of gene expression when their expression levels are reduced. Therefore both gain- and loss-of- function strategies are needed to fully exploit their therapeutic potential. miRNA research first focused on inhibition of single miRNAs using oligonucleotide inhibitors. However, more recent approaches explore the potential to deliver oligonucleotides to mimic miRNA expression or to employ small molecules to increase or inhibit miRNA function. Although we need to know more about the potential side effects and tissue specific delivery systems, these studies provide grounds to further exploit miRNAs as novel therapeutic targets in the clinic. Copyright Â
© 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  cancer; metabolism; microRNA; nanoparticles; oligonucleotide inhibitors; small molecules

Mesh:

Substances:

Year:  2016        PMID: 27923450     DOI: 10.1016/j.beem.2016.07.004

Source DB:  PubMed          Journal:  Best Pract Res Clin Endocrinol Metab        ISSN: 1521-690X            Impact factor:   4.690


  18 in total

1.  Downregulation of microRNA-142-3p and its tumor suppressor role in gastric cancer.

Authors:  Yi Wang; Zhidong Cao; Lanlan Wang; Siqi Liu; Jianqiang Cai
Journal:  Oncol Lett       Date:  2018-03-23       Impact factor: 2.967

Review 2.  MicroRNA-Directed Neuronal Reprogramming as a Therapeutic Strategy for Neurological Diseases.

Authors:  Irene Faravelli; Stefania Corti
Journal:  Mol Neurobiol       Date:  2017-06-29       Impact factor: 5.590

3.  miR-19a and miR-424 target TGFBR3 to promote epithelial-to-mesenchymal transition and migration of tongue squamous cell carcinoma cells.

Authors:  Duo Li; Ke Liu; Zhiyong Li; Jian Wang; Xiaofeng Wang
Journal:  Cell Adh Migr       Date:  2017-11-13       Impact factor: 3.405

Review 4.  Therapeutic Potential of miRNAs for Type 2 Diabetes Mellitus: An Overview.

Authors:  Pads Palihaderu; Bilm Mendis; Jmkjk Premarathne; Wkrr Dias; Swee Keong Yeap; Wan Yong Ho; A S Dissanayake; I H Rajapakse; P Karunanayake; U Senarath; D A Satharasinghe
Journal:  Epigenet Insights       Date:  2022-10-15

Review 5.  The Role of miRNAs in Angiogenesis, Invasion and Metabolism and Their Therapeutic Implications in Gliomas.

Authors:  Sasha Beyer; Jessica Fleming; Wei Meng; Rajbir Singh; S Jaharul Haque; Arnab Chakravarti
Journal:  Cancers (Basel)       Date:  2017-07-10       Impact factor: 6.639

6.  Modulating microRNAs as Novel Therapeutic Targets in Cardiac Fibrosis.

Authors:  Zhongxiu Chen; Yajiao Li; Ke Dian; Li Rao
Journal:  Theranostics       Date:  2017-06-01       Impact factor: 11.556

7.  lncRNA-MEG3 Suppresses the Proliferation and Invasion of Melanoma by Regulating CYLD Expression Mediated by Sponging miR-499-5p.

Authors:  Jianwen Long; Xianming Pi
Journal:  Biomed Res Int       Date:  2018-04-02       Impact factor: 3.411

Review 8.  Dysregulated MicroRNA Involvement in Multiple Sclerosis by Induction of T Helper 17 Cell Differentiation.

Authors:  Chen Chen; Yifan Zhou; Jingqi Wang; Yaping Yan; Lisheng Peng; Wei Qiu
Journal:  Front Immunol       Date:  2018-06-04       Impact factor: 7.561

9.  miR-223-3p Inhibits Human Osteosarcoma Metastasis and Progression by Directly Targeting CDH6.

Authors:  Quanbo Ji; Xiaojie Xu; Qi Song; Yameng Xu; Yanhong Tai; Stuart B Goodman; Wenzhi Bi; Meng Xu; Shunchang Jiao; William J Maloney; Yan Wang
Journal:  Mol Ther       Date:  2018-03-14       Impact factor: 11.454

10.  Increased expression of the microRNA 106b~25 cluster and its host gene MCM7 in corticotroph pituitary adenomas is associated with tumor invasion and Crooke's cell morphology.

Authors:  Filip Garbicz; Dawid Mehlich; Beata Rak; Emir Sajjad; Maria Maksymowicz; Wiktor Paskal; Grzegorz Zieliński; Paweł K Włodarski
Journal:  Pituitary       Date:  2017-08       Impact factor: 4.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.